Planned Science Cuts Could Hurt U.S. Economy

Proposed budget cuts to U.S. scientific research institutions would put the United States at an economic disadvantage with China and India, a former George W. Bush administration official says.

Scientific and environmental communities are raising alarm over proposed reductions of funding for their programs in a bill passed in the House of Representatives that would cut overall spending through September by about $61.5 billion from current levels.

Former Energy Department science chief Raymond Orbach said the bill's cuts in funding for research "would effectively end America's legendary status as the leader of the worldwide scientific community, putting the United States at a distinct disadvantage with other nations in the global marketplace."

"Other countries, such as China and India, are increasing their funding of scientific research because they understand its critical role in spurring technological advances and other innovations," Orbach wrote in an editorial in the journal Science.

The House passed the Republican-backed cuts on Feb. 19 in what was seen as a victory for Tea Party conservatives elected in November who advocate drastic reductions in government spending.

But Senate Democrats have said they will not bring the spending bill up for a vote in the Senate, where they have a majority, and the White House has threatened to veto the bill if it is sent to President Barack Obama in its current form.

Orbach, now director of the Energy Institute at the University of Texas at Austin, said the bill would take $900 million from the Office of Science at the Energy Department, a 20% reduction for that department's basic research arm.

The budget for the Office of Biology and Environmental Research would be cut in half, a move he said would "all but eliminate" funding for Biological Research Centers that aim to develop transportation fuels from plant sugars.

Other cuts would affect programs to develop solar power and other alternative, renewable energy sources.

Cuts To Climate-Change Programs
An analysis by the conservation group WWF said the House bill would improperly cut 30% of funding from the Environmental Protection Agency, and specifically prevent EPA from gathering data about climate-warming pollution from factories and power plants for the next seven months.

The EPA would be barred from updating national air quality standards to reflect new science, and from considering, reviewing or invalidating permits for drilling off the Alaska coast, WWF said in a statement.

The U.S. Fish and Wildlife Service would have 32% cut from its Multinational Species Conservation funds, while the National Oceanic and Atmospheric Administration would lose 8%, including all funding for its Climate Service program.

"Eliminating funds for EPA's climate programs and disrupting their ongoing regulatory efforts will only exacerbate the investment-freezing uncertainty that businesses need resolved to stimulate lasting economic growth," Eileen Claussen, president of the Pew Center on Global Climate Change, said in a statement.

David Crane, chief executive officer of NRG Energy , one of the largest U.S. power generators, said slowing down the EPA would keep aging inefficient power plants in place and delay tough choices companies need to make about replacing them.

"I think the EPA is just trying to enforce the laws of the U.S.," said Crane. "As long as there's consultation and things are done in a reasonable pragmatic way, I'd like to see the EPA continue."

Proposed cuts in health research also drew criticism - 5.2% in the budget of the National Institutes of Health for the next seven months, and 21% for the Centers for Disease Control and Prevention over the same period.

"The proposed cuts would mark a major setback in the fight against cancer," said John Seffrin of the American Cancer Society Cancer Action Network.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.